Oximinoarylsulfonamides as potent HIV protease inhibitors.

Article Details

Citation

Yeung CM, Klein LL, Flentge CA, Randolph JT, Zhao C, Sun M, Dekhtyar T, Stoll VS, Kempf DJ

Oximinoarylsulfonamides as potent HIV protease inhibitors.

Bioorg Med Chem Lett. 2005 May 2;15(9):2275-8.

PubMed ID
15837308 [ View in PubMed
]
Abstract

The need for a potent HIV protease inhibitor (PI) to combat emerging PI-resistant viruses is anticipated. Analogs formulated from the combination of structural fragments of Ritonavir, Lopinavir, and Amprenavir were synthesized. Analogs containing the oxime pharmacophore were found to have improved activities against both wild type and resistant (A17) viruses. The synthesis and structure-activity relationships (SAR) based upon the in vitro IC50 of this series of compounds are reported.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Gag-Pol polyproteinP03366Details